The CML disease is a common hematological malignancy that is caused by the uncontrollable enzymatic activity of a fusion protein known as Breakpoint Cluster Region-Abelson (BCR-ABL) [78]. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.